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ABSTRACT

Osteoarthritis is a joint disease characterized by the breakdown of articular cartilage. The field of
tissue engineering is interested in developing methods to produce biological alternatives to
current orthopedic procedures. Lubricin is a molecule which is important in the proper
lubrication of articular cartilage. It is a challenge in the field of tissue engineering to produce
cartilage with sufficient lubricin expression. Developing a reporter cell for lubricin allowed for a
more efficient investigation of the conditions which may influence its expression. By comparing
“optimized” and traditional media solutions, it was determined that the use of a previously
reported type II collagen optimized media would negatively affect the expression of lubricin.
This information indicates the need to further evaluate the conditions which are conducive to
producing cartilage with both sufficient types of type II collagen and lubricin.
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INTRODUCTION
The purpose of this project is to develop a lubricin reporter cell for drug discovery. Within this
project, confirmation of chondrogenic activity will be made with a known stimulator, TGF-β1.
Reporter cells were also used to compare lubricin expression between traditional chondrogenic
media and a physiologically optimized media solution which promotes type II collagen
expression [1]. This research is relevant to the topic of arthritis and the field of tissue
engineering. Lubricin is a molecule which is important in the proper lubrication of articular
cartilage. By developing a reporter cell for lubricin, it will allow for a more efficient
investigation of the conditions which may influence its expression. By comparing optimized and
traditional media solutions it can be determined if the use of type II collagen optimized media, a
marker of hyaline articular cartilage, would be beneficial to the expression of lubricin.
Cartilage is an avascular tissue with a low ability to repair itself when damaged. When cartilage
is damaged the healing process often leads to the formation of fibrocartilage, which is inferior in
function and mechanical properties than the native cartilage. For these reasons, surgical repairs
(short of total joint replacement) of cartilage often fail to remedy the problems associated with
OA and traumatic injury to the cartilage [2, 3]. Due to the fact that cartilage appears relatively
simple in construct and has a low ability for natural regeneration, it has been a particular focus in
the field of tissue engineering.
According to the World Health Organization “Osteoarthritis (OA) is one of the ten most
disabling diseases in developed countries”. Worldwide, it is estimated that about 9.6% of men
and around 18.0% of women over the age of 60 have developed symptomatic osteoarthritis [4].
In the United States alone, over 32.5 million people live with OA [5]. OA is an affliction which
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is commonly associated with increased age. Citing a long-term study from the University of
North Carolina the American College of Rheumatology states that, “the lifetime risk of
developing OA of the knee is about 46%, and the lifetime risk of developing OA of the hip is
25%” [6]. However, OA can affect more than just aging individuals. People who work in
agriculture have also been shown to have an increased risk of developing OA during their life
[4]. Additionally, younger people can develop OA as well. When younger people do develop
OA, it is commonly due to trauma or improper development of their joints [6]. Women are more
likely than men to have OA [5]. Other risk factors include obesity and a family history of the
disease [5].
Osteoarthritis is a painful and degenerative joint disease which affects articular cartilage and
subchondral bone [7]. Articular cartilage is responsible for maintaining a smooth surface for
joints to glide upon during movement [4]. Characteristically, OA involves the breaking-down of
the articular cartilage found in joints. This leads to changes in the bones, damage to tendons and
ligaments, and synovial inflammation. The classic symptoms of OA include stiff/painful
movement, knobby swelling, cracking, and decreased range of motion of the joint [6].
Currently, there is no known cure for osteoarthritis. Most current treatment options focus on
mitigating pain and improving joint function. These goals are accomplished in a few different
ways. Injections, nutrition control, and surgical options are being explored to help reach these
objectives. Injections of lubricants, such as hyaluronic acid, have been shown to provide pain
relief for months and even delay the need for orthopedic knee replacement for years [6]. It is
believed that nutrition can also be utilized to limit the inflammation in individuals with OA [6].
At this point however, according to the American College of Rheumatology “Most [over-the2

counter nutrition supplements] lack good research data to support effectiveness and safety”. The
major role of nutritional intervention is in reducing weight, thereby reducing forces in the joint.
Surgery is commonly a last resort treatment after medicine fails to provide relief. Depending on
the severity of the osteoarthritis, arthroscopy and joint replacements may become necessary to
deal with the disease [6].
Tissue Engineering (TE) is a field of study which is focused on addressing the deficit of donor
tissues and organs across the world and producing in vitro models that more accurately reflect
the in vivo reality. TE aims to accomplish this by developing healthy, biological alternatives to
direct tissue donation. A multidisciplinary approach in the fields of engineering, cell biology,
and molecular biology is being utilized to try and accomplish this aim [8]. Much of the work in
the field of tissue engineering focuses on aspects of what is known as the “tissue engineering
triad”. The tissue engineering triad includes a focal point on cells, biomaterials, and biofactors.
The cellular focus includes the investigation and manipulation of the expansive and
differentiative properties of the cells. The idea behind this is that these cells can be used to
create a “functional matrix” with the use of biomaterials. Biomaterials are often utilized in the
field of tissue engineering as scaffolds, which provide structure to the forming matrix of cells.
The third focus of the triad is biofactors. Biofactors include both biological and environmental
factors which influence the growth and differentiation of the cells. This can include the
investigation of hormones, vitamins, growth factors, and the other needs of the cell [9, 10].
Multiple avenues have been investigated concerning the cellular therapies aspect of cartilage
tissue engineering. Mature chondrocytes were one of the earliest cell types investigated when
looking into cellular therapies for cartilage damage. A method called autologous chondrocyte
3

implantation (ACI) has utilized mature chondrocytes with some success [11, 12]. Unfortunately,
the cells utilized in ACI offer an imperfect treatment as they tend to resemble fibrocartilage and
show increased type I cartilage production [13]. Additionally, the sourcing of mature
chondrocytes is challenging as doing so can affect the activity of the donor-site [12].
Mesenchymal stem cell therapies are being developed to help address some of the issues to
methods involving mature chondrocytes. Mesenchymal stem cells (MSCs) are able to be
harvested from diverse sources such as bone marrow, adipose tissue, and synovial fluid while
still maintaining their ability to differentiate into chondrocytes [14]. They also have shown
clinical improvement over ACI treatment [12, 14]. The problem with MSCs is that they
commonly overgrow the defect site and also progress to hypertrophy and calcification [15].
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have also demonstrated
a promising ability to form cartilages. Ethical issues surrounding ESCs, teratoma formation and
contaminating cell types (for both ESCs and iPSCs) remain to be challenges to the clinical
implementation of these technologies [12].
Similarly, the biomaterials aspect of tissue engineering has been closely studied. As a target of
tissue engineering, articular cartilage may at first appear to be a simple tissue. It is a tissue
which does not contain any vasculature and has relatively few cell types. Structurally however,
articular cartilage is highly organized in 3D space. Divided into the superficial, transitional, and
radial zones, the organization of the extra-cellular matrix (ECM) is largely responsible for many
of the functional properties of cartilaginous tissue [16, 17]. For example, it has been shown that
while the superficial zone may experience relatively low hydrostatic pressure under load, the
deep zone is specialized to withstand higher levels of hydrostatic pressure [18]. For these

4

reasons, biomaterials provide an important solution to the structural component of cartilage
engineering.

Figure 1 – Organization of articular cartilage. Articular cartilage is made up of several different zones with
different properties. In the superficial zone, cells are more flattened and express lubricin. The transitional zone
contains spherical chondrocytes at low density, allowing for resistance to compressive forces [19]. The radial zone
contains collagen fibers which are perpendicular to the articular surface and axially arrange chondrocytes. This zone
provides the greatest resistance to compressive forces[19]. Beyond the radial/deep zone is calcified cartilage, which
is important in securing the articular cartilage to the underlying bone. Figure created with BioRender.com.

The effects of biological and environmental factors are crucial to the development of cartilage
engineering techniques. Growth factors are an example of a group of biological factors which
are necessary for stimulating cellular growth and differentiation. In articular cartilage, many
different growth factors work together continuously to maintain the tissue [20]. TGF-β and BMP
families are particularly important in cartilage engineering due to their role in stimulating
chondrogenesis [20, 21]. TGF-β1 accomplishes this in part by stimulating fibronectin, an
5

important ECM component [20]. TGF-β1 is of particular interest to this paper because it has
been shown to stimulate lubricin accumulation in muscle-derived mesenchymal stem cells [22].
Beyond biological factors, environmental factors such as oxygen tension and mechanical stimuli
have been shown to affect chondrogenesis [23]. Hypoxic conditions have been shown to both
increase the synthesis of the ECM and promote chondrogenic differentiation. This same study
also revealed that markers of chondrocyte hypertrophy were also reduced [24]. Mechanical
stimuli plays an important role in both stimulating chondrogenic differentiation and maintaining
the already existing cartilage [23, 25]. The availability of the appropriate vitamins and minerals
is also important to cartilage formation and maintenance. It has been demonstrated that by
supplementing media with the appropriate vitamins and minerals which are currently lacking, the
expression of type II collagen can be increased [1].

6

Figure 2 – Pathway for TGF-β1 stimulation of lubricin expression. Mature TGF-β1 binds to the TGF-β1
receptor, which consists of two type I (ALK5) subunits and two type II (TGF-β RII) subunits [26]. The type II
subunits phosphorylate the type I subunits when bound [26]. The activated type I subunits phosphorylate the Smad
2/3 complex with Smad 4 which then translocates to the nucleus to induce expression of the target genes [26].
TGF-β1 has been associated with increased ECM and proteoglycan synthesis, specifically type II collagen
(COL2A1) and lubricin (PRG4) [27]. Adapted from [26].

This paper focuses on lubricin, a molecule which is incredibly important in synovial joints. Over
the course of a lifetime, joints are constantly moving. They will experience compressive and
frictional forces many millions of times. The knee for example, has to endure an enormous
amount of stress when undertaking common activities such as walking, running, and jumping.
The coefficient of friction is closely related to the amount of wear a joints experience. Damage
to opposing cartilage surfaces is minimized by a low coefficient of friction [28]. As previously
stated, cartilage has a low ability for regeneration. Therefore, wear and tear in the joint must be
minimized to prevent disability over the course of a human life. Due to these assertions, it is
7

important for lubricants to be present in synovial joints to help reduce the coefficient of friction.
Aptly named lubricin is a molecule which functions as a lubricant in synovial joints.
Lubricin is an approximately 227 kDa extensively O-linked glycoprotein encoded by the gene
PRG4 [29, 30]. PRG4 is highly conserved across mammalian species, indicating its evolutionary
importance [30]. This gene was originally referred to as megakaryocyte-stimulating factor, due
to a 32 kDa protein fragment which has been shown to stimulate megakaryocyte growth in vitro
[30]. The primary expression of lubricin occurs at the superficial zone chondrocytes, but
expression has been noted at lower levels in the intermediate zone [30]. Synovial fluid
containing lubricin was shown to reduce the coefficient of friction even when hyaluronic acid
(HA) was digested with hyaluronidase [29]. It is notable to this paper that lubricin protects
against the development of post-traumatic osteoarthritis in a murine model [31]. Lubricin’s role
in maintaining joint integrity was demonstrated in individuals with camptodactyly-arthropathycoxavara-pericarditis (CACP). In CACP, individuals demonstrate premature joint deterioration
due to a mutation in the gene encoding lubricin [32]. Similarly, lubricin degradation in
inflammatory joint diseases has been linked to a predisposition to cartilage degradation [33].
While lubricin has been shown to reduce the coefficient of friction without HA, it has been
proposed that HA complexes with lubricin in order to mechanically reduce wear [34, 35]. Tissue
engineered cartilage typically shows little, if any, expression of lubricin [36]. It has been
proposed that methods of modulating lubricin in engineered cartilage will be essential for
successful cartilage tissue formation [36].
Many of the researchers who are interested in cartilage tissue engineering [1, 37-39] have
utilized a defined, serum-free chondrogenic media in order to engineer cartilage in vitro.
8

Originally, chondrogenic media utilized fetal bovine serum to supplement for vitamins and other
components which would have been missing from a defined medium. However, the field of
cartilage tissue engineering has moved from a serum containing media, as described in [40], to a
serum-free media, as published by [41]. This shift towards a defined media, allows for a greater
control of the conditions which influence cartilage development. However, as pointed out in [1],
the currently used Dulbecco’s Modified Eagle’s Medium (DMEM) lacks several vitamins and
minerals which may have important implications to the development of healthy cartilage. This
paper is focused on investigating whether or not the supplementation of these vitamins and
minerals to the composition of DMEM will increase the development of cartilage and the
expression of lubricin on the cells. Previously, a COL2A1-Gaussia luciferase reporter system
was used to determine the effects of many different vitamins and minerals [1]. This study found
that “while not all components promote COL2A1 promoter-driven expression, they can still have
an effect on chondrogenesis, such as through the stimulation or inhibition of metabolism”.
Further investigation is needed to determine how a composition of DMEM which has been
“optimized” with potentially relevant vitamins and minerals may influence the expression of
lubricin.
This paper develops and validates cells which can be used in high-throughput methodology for
data collection. The work done in [1] demonstrates a 96-well aggregate chondrogenic assay
which was utilized to “screen chondrocytes transduced with a Gaussia luciferase (gLuc) reporter
driven by a type II collagen promoter”. This previous study’s methodology was adapted for use
in chondrocytes transduced with a Gaussia luciferase reporter driven by a lubricin promoter.
The aggregate chondrogenic assay [42] which this technique is derived from, allows for
induction of in vitro chondrogenesis in a reproducible culture system. Gaussia luciferase is a
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secreted photoprotein which was isolated from the marine organism Gaussia princeps [43].
Gaussia luciferase is the smallest known luciferase [44] and emits a light peak at 480 nm [43].
As a secreted protein, gLuc assays are able to be performed without harming the cells being
analyzed. These properties make it a promising candidate for reporting the expression of
proteins. Gaussia luciferase assays are also beneficial to a high-throughput system because they
are rapid, able to be performed in minutes rather than hours or days [45]. Another highthroughput technique which is presented in this paper is the assessment of chondrogenesis
through imaging. By imaging the cell aggregates regularly, using biological image processing
software, growth can be quantified across multiple media compositions.
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METHODS AND RESULTS
Developing ATDC5 Lubricin Reporter Cells
Isolating a Promoter-Driven Gaussia Luciferase Plasmid
A custom-ordered PRG4 promoter-driven Gaussia luciferase lentiviral plasmid [Figure 3]
(HPRM34762-LvPG02, GeneCopoeia, Inc.) was grown in E. coli overnight and purified by
using a miniprep kit (Invitrogen). The DNA content was analyzed for quality and concentration
by using a Nanodrop spectrophotometer (ThermoFisher). The isolated plasmid was then
confirmed by using restriction enzyme digestion (EcoR1/BamHI) with agarose gel
electrophoresis (Fisher Scientific Mini Gel System). Following the positive confirmation of the
desired plasmid, a 90 mL overnight culture containing the plasmid was then prepared. The
plasmid was isolated via a maxiprep kit (Zymo Research). Similarly, this plasmid was then
analyzed by Nanodrop, which showed a concentration of ~600 ng/µL, a 260nm/280nm ratio of
1.86, and a 260nm/230nm ratio of 2.21. This indicated that the plasmid was sufficiently purified
to proceed with the experiment. Finally, the plasmid was characterized a second time by
restriction enzyme digestion and agarose gel electrophoresis [Figure 4].
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Figure 3 – PRG4 promoter-driven Gaussia luciferase plasmid map. The PRG4 promoter is 1548 base pairs.
Gaussia Luciferase is present as a reporter gene. Puromycin is the stable selection marker. A gene for ampicillin
resistance is also included for bacterial selection of the plasmid.

Figure 4 – Gel electrophoresis of PRG4 plasmid. From left to right: Generuler 1 Kb ladder, uncut PRG4-gLuc
plasmid, EcoRI digested PRG4-gLuc plasmid 1, EcoRI digested PRG4-gLuc plasmid 2, EcoRI digested PRG4-gLuc
plasmid 3, and a second Generuler 1 Kb ladder. A simulated ECORI digestion of the PRG4-gLuc plasmid on
Benchling.com results in a single cut with a 9394 base pair gene fragment. This gel appears to be consistent with
the simulated gel restriction digestion.
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Isolating the Lentiviral Envelope and Packaging Plasmids
The lentiviral envelope and packaging plasmids, pMD2.G (addgene #12259) and psPAX2
(addgene #12260) respectively, were grown in E. coli (GCI-L3, GeneCopoeia) overnight and
selected for via ampicillin. The plasmids were then characterized by utilizing a miniprep and
agarose gel electrophoresis. Once the plasmids were confirmed, a maxiprep was performed on a
90 mL overnight culture for each plasmid. The isolated plasmids were verified by restriction
enzyme digestion and agarose gel electrophoresis [Figure 5]. A Nanodrop spectrophotometer
was used to analyze the purified plasmid for DNA quality and concentration. The nanodrop and
gel confirmed the plasmids were sufficiently purified and the correct size for the desired genes.

Figure 5 – Gel electrophoresis of lentiviral plasmids. From left to right: Generuler 1 Kb ladder, BamHI digested
psPAX2, BamHI digested pMD2.G 1, BamHI digested pMD2.G 2, and a second Generuler 1 Kb ladder. A
simulated BamHI digestion of the psPAX2 plasmid on Benchling.com results in an 810 and 285 fragment. The
simulated BamHI digestion of pMD2.G showed a band at 5,000 base pairs. This gel appears to be consistent with
the predicted BamHI digestion of the desired plasmids.
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Transfecting HEK293Ta Cells
HEK-293Ta (GeneCopoeia) cells were transfected via calcium phosphate precipitation [46] with
the PRG4-gLuc, psPAX2, and pMD2.G plasmids. This transfection was used in order to
generate pseudolentiviral particles for the PRG4-gLuc infection of ATDC5. 24, 48 and 72-hours
after transfection the pseudolentiviral particles were harvested from the conditioned medium. A
total of 300 mL of conditioned media was collected and ultracentrifuged (30,000 RCF, 8h, 4°C)
to produce a concentrated supernatant sample of lentiviral particles.
Assessment of lentiviral particle concentration with qPCR Titration
Samples of the conditioned media from the transfected cells were taken in order to perform a
HIV qRT-PCR titration. A GeneCopoeia HIV qRT-PCR Titration Kit was utilized to assess the
lentiviral concentration in the conditioned media and concentrated sample. A lentiviral standard
curve was generated based on lentiviral standard concentrations which were included in the kit
[Figure 6]. This confirmed the pseudolentiviral particles were present in the in the media. The
average CT values for the day 2, day 3, and concentrated supernatant were 31.24, 33.80, and
27.37 respectively. The day 1 supernatant did not register a CT value. Based on a calculated
dilution factor of 208.33, the day 2, day 3, and concentrated supernatant showed 1124.7, 160.4,
and 21242.4 copies per mL. However, it should be noted that only the concentrated supernatant
sample had a cycle threshold which fell into range of the standards. Later puromycin selection
of infected ATDC5 cells also is indicative of a higher copy per mL level than estimated here [see
ATDC5 Cell Infection].
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Lentiviral Standard Curve
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Figure 6 – Lentiviral standard curve. Generated from known concentrations of lentiviral particles. The
logarithmic trend line represents the lentiviral standards well with a R2 value of 0.9749. The 1x10^8 lentiviral
concentration is excluded due to potential evaporation from the qPCR well.

ATDC5 Cell Infection
ATDC5 cells were then thawed from frozen stocks and cultured in growth media (DMEM-LG
supplemented with 10% FBS and 1% penicillin/streptomycin) and grown to 80-90% confluence
in a humidified 37°C 5% CO2 incubator (Thermo Scientific). Cells were passaged into 24 well
plates (11,400 cells/well) and infected with pseudolentiviral particles. Polybrene was utilized in
this experiment because it has been shown to reduce repulsion forces between lentiviral particles
and the target cells, therefore increasing transduction efficiency [47].

A 10 mg/mL stock of

polybrene was diluted to 8 µg/mL with ATDC5 growth media. To a 24-well plate containing the
ATDC5 cells, 100 µL of the diluted polybrene was added. A 100 µL aliquot of the PRG4-gLuc
pseudolentiviral particles was diluted with opti-MEM to 450 µL and subsequent 1:10 dilutions
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were performed to give five separate concentrations: 1x, 0.1x, 0.01x, 0.001x, 0.0001x. A control
containing no pseudolentiviral particles, 0x, was also present. The plates were then incubated at
4°C for 20 minutes and then moved to the 37°C, 5% CO 2 atmospheric oxygen incubator
overnight. Upon observation in the morning, the 1x lentiviral infection concentration cells
appeared highly perturbed due to the toxic effects of the high lentiviral concentration, these cells
later underwent necrosis. Similarly, the 0.1x lentiviral infection cells initially appeared mildly
perturbed by the infection, but later recovered. The media was then changed, and the cells were
allowed to grow to 90% confluence. Cells were then passaged by incubation with
trypsin/EDTA, neutralized with growth media and replating at a ~1:10 dilution. After passaging
the cells, infected cells were isolated by using puromycin treated growth media. Images were
taken before and after puromycin selection at 10X magnification (Keyence BZ-X800) and
showed a puromycin survival rate of 90.4% for the 0.01x concentration and 89.2% for the 0.1x
concentration. The 0x-0.001x concentrations had a 100% death rate in puromycin. Based on a
titer chart relating multiplicity of infection (MOI) to the percentage of infected cells [48], an
estimated multiplicity of infection of 2.3 was determined. From this a calculated 120,000,000
transducible units were present per mL of lentiviral stock used, which differs from the data
calculated in [Figure 6]. The 0.1x concentration likely had a higher number of transducible units
than the 0.01x infection concentration, but the toxic effects of the lentivirus at the higher
concentration likely limited the number of cells which could be viably infected. Following
puromycin selection, the cells were grown in standard ATDC5 growth medium and passaged
before differentiation.
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Confirming Infection of ATDC5 Cells
Infection of selected ATDC5 cells was confirmed by luciferase assay (Perkin Elmer EnVision
Plate Reader) [Figure 7] and RT-qPCR analysis (QuantStudio, Thermo Fisher) [Figure 8]. The
luciferase assay indicated the presence of a functional Gaussia luciferase gene in the puromycin
isolated cells. Additionally, the data from the gLuc assay for each lentiviral concentration
provided a quantitative means for assessing to what extent the PRG4-gLuc gene was integrated
into the ATDC5 cells’ DNA. The higher concentration of lentiviral particles resulted in a
stronger luminescence reading. The RT-qPCR was performed in order to quantitatively
determine the RNA expression of the PRG4 and gLuc genes in the puromycin selected reporter
cells. Primers used for this RT-qPCR are listed in [Table 1]. However, the mPRG4 primer
utilized for this qPCR did not result in producing a distinct melt curve peak or produce a cycle
threshold value. It is likely this mPRG4 primer is nonfunctional. A different mPRG4 primer set
was used for subsequent PRG4 gene amplification in ATDC5 cells. The amplification of the
Gaussia luciferase gene by the gLuc primers was consistent with a successful infection.
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Figure 7 – Luciferase response from ATDC5 cells infected with lentiviral PRG4-gLuc. The higher infection
concentrations resulted in a higher amount of luminescence in the infected ATDC5 cells. This demonstrates the
luciferase gene is functional in the infected cells. p values less than 0.05 are shown.

Target
Gene
gLuc

Function of Gene

Forward Primer Sequence

Reverse Primer Sequence

mPRG4*

Promoter driven
reporter
Lubricin Production

mHPRT

Reference Gene

mPPIA

Reference Gene

ACG CTG CCA CAC CTA
CGA
GGG TGG AAA ATA CTT
CCC GTC
AAG TTT GTT GTT GGA
TAT GCC C
GGT CCT GGC ATC TTG
TCC AT

CCT TGA ACC CAG GAA
TCT CAG GAA
CAG GAC AGC ACT CCA
TGT AGT
CTC ATC TTA GGC TTT
GTA TTT GGC
GCC TTC TTT CAC CTT
CCC AAA

Table 1 – Primers used for RT-qPCR validation of ATDC5-PRG4-gLuc Infection. *This PRG4 primer pair did
not amplify in our study.

18

gLuc Copies per Geometric Mean of mPPIA and
mHPRT

Gaussia Luciferase Copies per Geometric Mean of mPPIA and
mHPRT vs. Lentiviral Infection Concentration
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Figure 8 – Lentiviral Infection gLuc RT-QPCR Data. Gaussia Luciferase copies per Geometric Mean of mPPIA
and mHPRT vs. Lentiviral Infection Concentration. Data is based on cDNA produced from normalized RNA (9.28
ng/well) quantities isolated from infected ATDC5 cells. The utilized PRG4 primer is likely nonfunctional as it did
not result in any amplification. Despite this the gLuc CT values indicate the lentiviral infection was successful.

Comparing the Expression of Lubricin Between Current and Type II Collagen Optimized
Media in ATDC5 Cells
Generating a TGF-β1 Dose Response Curve for Infected ATDC5 Cells
To establish the ATDC5-PRG4-gLuc reporter cells as a viable model, a TGF-β1 dose response
curve was generated [Figure 9]. TGF-β1 is a known stimulator of chondrogenesis and lubricin
[27]. The TGF-β1 dose response curve allowed for comparisons between the normalized
luminescence values from temporal Gaussia luciferase assays of a chondrogenic cell aggregate
in a 96-well plate. Additionally, microscope images were obtained for size quantification of the
cell aggregates temporally [Figure 10]. Doses of TGF-β1 in basal chondrogenic media (DMEMHG supplemented with 1% penicillin/streptomycin; 100 nM dexamethasone; 1% insulin,
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transferrin, selenium + premix; 2 mM GlutaMax; 1% sodium pyruvate; 1% MEM non-essential
amino acids; 130 mM ascorbate-2-phosphate; and 1.25 µg/mL fungizone) at 10 ng/mL, 1 ng/mL,
0.1 ng/mL 0.01 ng/mL, 0.001 ng/mL, and a 0 ng/mL control were compared for ATDC5 cells
and the ATDC5-PRG4-gLuc reporter cells. Each cell aggregate was seeded at 50,000 cells in
200 µL of TGF-β1 containing media to give the dose response curve. For cell feedings 150 µL
was removed, with 20 µL used for the Gaussia Luciferase assays and the rest discarded, and 150
µL of the corresponding TGF-β1 containing chondrogenic medias were used for cell feedings.
Cell feedings occurred M/W/F with imaging. Luciferase assays were performed after cell
feedings on W/F. Data was collected in sextuplicate for the 21-day experiment. Luminescence
values were normalized relative to the 0 ng/mL TGF-β1 condition for the ATDC5 and ATDC5PRG4-gLuc cells separately. A dose response curve was fit by using GraphPad Prism’s
log(agonist) vs. response (three parameter) nonlinear fit analysis. The dose response curve was
used to determine the EC50 at days 7, 14, and 21. The EC50 is the concentration of TGF-B1
which gives half of the maximal response [49].
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Figure 9 – TGF-Β1 Dose Response for ATDC5-PRG4-gLuc. Data is normalized to the 0ng/mL TGF-B1
ATDC5-PRG4-gLuc control condition. Fitted to this Data is a dose response curve for each day shown. EC50’s at
Day 7, 14, and 21 are: 4.651 ng/mL, 5.789 ng/mL, and 6.578 ng/mL respectively. The R 2 values for these dose
response curves are 0.9501, 0.9617, and 0.9598. The ATDC5-PRG4-gLuc cells were responsive to the increasing
doses of TGF-β1 throughout the experiment.

Figure 10 – ATDC5-PRG4-gLuc TGF-β1 Pellet Area by TGF-β1 Dose. Also shown on this graph are the
uninfected ATDC5 control cells. These control cells show a similar response to TGF-Β1 at 10 ng/mL and 0 ng/mL
as the PRG4-gLuc infected ATDC5 cells. This response indicates that the lentiviral infection did not significantly
alter the cell expansion trends both with and without the presence of TGF-Β1. Multiple Two-wave ANOVA test

21

performed using GraphPad Prism software indicates that the mean values between each experimental condition
shown above are statistically significant from one another, with P-values <0.001. Error bars shown indicate a 95%
confidence interval.

Comparing Basal, COL2A1 Optimized Media, and Theoretically COL2A1 Optimized Media
Solutions in ATDC5-PRG4-gLuc Cells
For this experiment three media solutions were prepared: a type II collagen optimized media
solution from the two vitamin/mineral supplementations (Vitamin K and Copper) which showed
the most promising results in [1], a theoretically optimized media for type II collagen solution
[See Table 2], and a basal media. Each of the prepared medias were supplemented with 1 ng/mL
of TGF-β1, as the cytokine has been shown to upregulate chondrogenesis in ATDC5 cells [50]
and in other mammalian cells [51].
COMPONENT

FINAL MEDIA CONCENTRATION

α-linolenic acid

0.54 mg/L

Chromium

0.28 µg/L

Cobalt

90 pg/L

Copper

6.7 µg/L

Iodine

92 ng/L

Manganese

12 ng/L

Molybdenum

0.2 ng/L

Thyroxine

25 pg/L

Vitamin A

78 ng/L

Vitamin B7

3 ng/L

Vitamin B12

914 ng/L
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Vitamin D

8.6 pg/L

Vitamin E

18.4 mg/L

Vitamin K

11 µg/L

Zinc

120 ng/L

Table 2 - Proposed Supplements to Defined Chondrogenic Media [1]. This table shows the desired final media
concentrations for the theoretically optimized media solutions. This table was produced as a result of the study
performed in [1]. This media was created by producing a 2000x stock for both the ethanol and water-soluble
vitamins. The 2000x ethanol soluble vitamins were dissolved in 200-proof ethanol while the 2000x water soluble
vitamins were dissolved in ultra-pure H2O. The 2000x stocks were added to the 1 ng/mL TGF-Β supplemented
basal +chondrogenic media at 0.5 µL/mL.

The other “optimized” media solution which this paper intends to evaluate is based on the best
luciferase responses from [1]. That response was obtained at a final concentration of 2.2 µg/L of
Vitamin K and 670 ng/mL of Copper. The basal media condition was prepared by
supplementing the 1 ng/mL of TGF- β1 basal chondrogenic media with 0.5 ng/mL of 200-proof
ethanol and 0.5 ng/mL of ultrapure H2O will be added to account for any affects which these
substances may exert on the theoretically optimized media.
To compare the basal, optimized, and theoretically optimal chondrogenic medias a 21-day 96well aggregate chondrogenic experiment was prepared. ATDC5, ATDC5-Col2-gLuc, and
ATDC5-PRG4-gLuc cells were seeded at 50,000 cells in 20 µL of basal chondrogenic medium
as shown in [Figure 11]. The basal, optimized, and theoretically optimized media were added for
a final 100% concentration in each well. The concentrated media was then diluted for
subsequent feedings. The plate was centrifuged at 500 RCF for 5 minutes in order to form the
cell aggregates. All of the unfilled wells were filled with 200 µL of PBS in order to limit any
evaporation from the outermost wells. This plate was set to incubate at 37°C in a 5% O 2
physioxic incubator.
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The cells were fed on a M/W/F schedule throughout the 21-day experiment. A total of 150 µL of
media was removed and replaced with 150 µL of the appropriate chondrogenic media. Cells
were imaged M/W/F on the ImageXpress Pico for ImageJ analysis [Figure 12]. On Wednesdays
and Fridays, 48 hours after feeding, 20 µL of the conditioned media was used in a luciferase
assay to assess the luminescent activity of the chondrocytes [Figure 13].
After the 21-day experiment was complete, cells were harvested for histology and RT-qPCR
analysis. One pellet from each column [Figure 11] was fixed in formalin and then and put into
paraffin wax for sectioning (5 µm). Histological staining targeting the nuclei, cytoplasm, and
glycosaminoglycan was then performed [Figure 16]. The pellets not used in histological analysis
had their RNA purified and cDNA was produced from a normalized RNA quantity. The cDNA
was then analyzed via RT-qPCR (Purelink, Invitrogen). The same primers as listed in [Table 1]
were used with the exception of a working mPRG4 primer [Table 3]. Expression of PRG4 and
the gLuc gene were evaluated from the qPCR data [Figures 14, 15].
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Figure 11 – ATDC5 Optimized Media Plate Experiment Layout. Figure created with Biorender.com
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Figure 12 – ATDC5 Optimized Media Experiment Pellet Area Data. The above graphs show the raw ImageJ
data for the pellet area over time for each of the conditions tested. Error bars indicate a 95% confidence interval.
For the ATDC5 and ATDC5-PRG4-gLuc pellets, pellet area increased over time. The ATDC5-Col2-gLuc cells
interestingly decreased in size initially, but then maintained a mostly consistent area. Two-wave ANOVA statistical
analysis performed using GraphPad Prism software indicates that A. and B. have P values of 0.45 and 0.35
respectively, which indicates that the media conditions for ATDC5 and ATDC5-Col2-gLuc pellets did not have a
significant effect on the mean area values. Two-wave ANOVA analysis did indicate that C. had a significance
difference between mean area values for different media conditions, with a P value of <0.001. Temporal statistical
difference between conditions is shown in Appendix B. In a model normalizing the pellet area from the initial day
two imaging (data not shown) the change in area relative to day 2 in the ATDC5-PRG4-gLuc pellets was not
significantly different across media conditions, with a P value of 0.48.
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Figure 13 – ATDC5 Optimized Media Experiment Luminescent Assay Data. For time comparisons of the
luciferase response between medias, the data was normalized to the control media for each day. Error bars indicate
a 95% confidence interval. A Two-wave ANOVA analysis was performed for each of the above data sets using
GraphPad Prism software, stars indicate a statistically significant difference (P <0.05) between mean luminescence
values and the control. A. Total luminescence values for the uninfected ATDC5 control pellets were much lower
than the in the infected cell lines. Average luminescence values for the uninfected cells were typically below 15,000
while the PRG4-gLuc infected cells ranged from values of ~40,000-~400,000. No significant difference between
mean values was shown between the control and optimized media conditions with a P value of 0.60. The control
and theoretical media conditions had a significant difference in mean luminescent values with a P value of <0.001.
The lower luciferase readings for the theoretically optimized media is likely explained by oxidation inhibitors
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reducing autocatalysis in the supplemented media. B. Media conditions for the ATDC5-Col2-gLuc pellets did not
result in a significant difference in mean luminescence values between the control and theoretical medias with a P
value of 0.32. However, a statistically significant difference was shown between the control and optimized media
conditions, with a P value of 0.001. The type two collagen reporter pellets (ATDC5-Col2-gLuc) showed a relative
increase in luminescence for the optimized media condition when compared to the control media. The theoretically
optimized media had no significant changes in luminescence when compared to the control for the ATDC5-Col2gLuc pellets. C. A significant difference was seen between the mean luminescent values between both “optimized”
conditions and the ATDC5-PRG4-gLuc control, P values were both <0.001. This experiment is interested in
determining the differences between current and optimized conditions. The raw luminescence value for the ATDC5
pellets as well as a day by day breakdown can be seen in Appendix A.

Figure 14 – ATDC5 Optimized Media Experiment gLuc Expression from RT-qPCR Data. Relative gene
expression of Gaussia Luciferase normalized to the geomean of the reference genes, mPPIA and mHPRT. Data was
collected in duplicate from cDNA produced from a normalized amount of RNA. The ATDC5-Col2-gLuc
expression of Gaussia Luciferase followed the trends seen in [Figure 13 – B]. The ATDC5-PRG4-gLuc expression
of Gaussia Luciferase did not closely follow the trends seen in [Figure 13 – C], which is discussed further in the
[DISCUSSION] portion of this paper. Uninfected ATDC5 pellets did not show significant amplification of Gaussia
luciferase.

Target
Gene
mPRG4

Function of Gene

Forward Primer Sequence

Lubricin
Production

CGG CCT GCC ATC AAC
TAC TC
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Reverse Primer Sequence
TCA TTG TGG AGG AAA
CCT TTG T

Table 3 – New mPRG4 primer used to determine expression of PRG4 in optimized media experiment pellets.
Primer was developed using Primer-BLAST [52].

Figure 15 – ATDC5 Optimized Media Experiment PRG4 Expression from RT-qPCR Data. Relative gene
expression of Lubricin as compared to the geomean of the reference genes, mPPIA and mHPRT. Data was collected
in duplicate. ND indicates that the gene was not detected in 45 PCR cycles. RNA quantity was normalized prior to
cDNA synthesis. The data shown in this figure did not closely follow the trends seen in the results shown in
[Figures 13, 14], which is discussed further in the [DISCUSSION] portion of this paper.
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Figure 16 – ATDC5 Optimized Media Experiment Histology Images. Cartilage tissue stained with hematoxylin,
Fast Green, and Safranin O solution. This stain should show dark nuclei, gray-green cytoplasm, and orange-red
sulphated glycosaminoglycan [53]. a: Cartilage sheet sectioned and stained as control, showing a well-developed
glycosaminoglycan rich matrix staining bright red. b: ATDC5 control pellet 0 ng/mL TGF-B1. c: PRG4 10 ng/mL
pellet. d: PRG4 optimized media pellet. e: PRG4 theoretically optimized media pellet. Each pellet stained mostly
gray-green without any noticeable safranin-O staining. No noticeable differences was observed between the stained
sections in the figure above. Pellets from each condition not shown in the figure above were lost during tissue
processing due to small pellet diameter.

Developing a Human Articular Cartilage Lubricin Reporter Cell
For a lubricin cell reporter which is more relevant to osteoarthritis in the human body, human
articular cartilage cells isolated from discarded cell from a total joint arthroplasty surgery were
developed into a human articular cartilage lubricin reporter cell (HAC-PRG4-gLuc). The
osteoarthritic nature of these cells makes them a good model for the osteoarthritic tissue
engineering. To accomplish this, the PRG4-gLuc pseudolentiviral particles generated previously
in the HEK-293-Ta cells were used to infect the human articular cartilage cells. Multiplicity of
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infection calculations performed from the ATDC5 pseudolentiviral infection data along with the
qPCR and luminescence data were used to determine the optimal concentration for infection. It
was determined that the 0.01x concentration of lentiviral particles was the desired infection
concentration. The human articular cartilage cells were thawed from their initial post-collection
freeze the day before infection. A negative control was also “infected” with a 0x lentiviral
concentration. The plates were then incubated at 4°C for 20 minutes and then moved to the 37°C
atmospheric incubator overnight. The media was changed 11 hours after infection, and the cells
were allowed to grow to ~90% confluence. After passaging the cells onto a devitalized
synoviocyte matrix flask, infected cells were isolated using puromycin (2 ug/mL). Cell were
also passaged onto a six well plate and treated with puromycin (2 µg/mL) to allow for
microscopy determination of live/dead cells. Puromycin selection continued for a week. On day
2 imaging it was observed that none of the uninfected control cells were alive. At this time,
62.2% of the HAC-PRG4-gLuc cells were present in the puromycin condition as compared to the
identically prepared, non-puromycin condition. This indicated that approximately 62.2% of the
cells were successfully infected. Following puromycin selection, the remaining cells were grown
in the standard HAC growth medium and passaged before differentiation.
The isolated HAC cells were then confirmed through a luciferase assay [Figure 17]. The
luciferase assay showed a functional Gaussia luciferase gene was present in the puromycin
isolated cells, suggesting a successful infection.
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Luciferase Assay of HAC-PRG4-gLuc Infection
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Figure 17 – Luminescent Response of CP9-2017 HAC-PRG4-gLuc Infection. This figure demonstrates that an
active luciferase gene is present in the HAC-PRG4-gLuc cells when compared to a 0x lentiviral concentration
control. The luminescence value recorded for the uninfected control HAC cells is consistent with the typical
background luminescent detection.

Generating a HAC-PRG4-gLuc TGF-β1 Dose Response Curve
In order to determine the utility of HAC-PRG4-gLuc cells as a chondrogenic reporter cell, a 21day cell aggregate TGF-β1 experiment was performed. This 21-day experiment was carried out
in very much the same way as the ATDC5-PRG4-gLuc TGF-β1 dose response curve 21-day
experiment was. This experiment was duplicated, with one plate being incubated at atmospheric
oxygen tension and one plate being incubated at physioxic oxygen tension throughout the
experiment. Doses of TGF-β1 in basal chondrogenic media chondrogenic media at 10 ng/mL, 1
ng/mL, 0.1 ng/mL 0.01 ng/mL, 0.001 ng/mL, and a 0 ng/mL control were compared for the
HAC-PRG4-gLuc reporter cells. Each cell aggregate was seeded at 50,000 cells in 200 µL of the
TGF-β1 containing medias to produce a dose response curve. The pellets were fed with 150 µL
of the appropriate media MWF. Luciferase assays were performed WF, 48 hours after the
previous feedings, to assess luminescent activity.
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Figure 18 – HAC-PRG4-gLuc TGF-Β1 Dose Response Curve in Atmospheric Oxygen Tension. Data is
normalized compared to the 0x ATM O2 TGF-B1 HAC-PRG4-gLuc condition. TGF-Β1 dose response only
becomes significant in concentrations exceeding 1 ng/mL. The EC50 for day 5 was 7.864 ng/mL TGF-Β1. The day
14 and day 21 EC50s could not be determined without extrapolation beyond the tested concentrations. A Two-wave
ANOVA analysis performed using GraphPad Prism software shows a statistically significant difference due to the
log dose of TGF-B1 with a P-value of <0.001.

Figure 19 – HAC-PRG4-gLuc TGF-Β1 dose response curve generated in Physioxic Oxygen tension (5% O2).
Data was normalized to the 0x PHY O2 HAC-PRG4-gLuc control pellets. TGF-Β1 dose response only becomes
significant in concentrations exceeding 1 ng/mL. The EC50 for days 5, 14, and 21 were 5.22, 1.65, and 2.06 ng/mL
respectively. A Two-way ANOVA analysis performed using GraphPad Prism software shows a statistically
significant difference due to the log dose of TGF-B1 with a P-value of <0.001.
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DISCUSSION
ATDC5 Optimized Media Experiment
ATDC5 cells were successfully infected through a lentiviral vector with a PRG4 promoter driven
Gaussia luciferase plasmid. This was confirmed through subsequent puromycin selection,
luciferase assays [Figure 7], and RT-qPCR analysis [Figure 8]. The ATDC5-PRG4-gLuc cell
luminescence was responsive to increasing doses, 0.1 ng/mL up to at least 10 ng/mL, of TGF-Β1
[Figure 9]. The data demonstrates that over time lubricin’s response to TGF-β1 decreases, at
least for the lower concentrations tested in this experiment. Together, the data collected suggests
that luciferase activity is correlated to TGF-B1 stimulated lubricin upregulation, as has been
previously reported [1, 22, 26].
The “optimized” media conditions did not significantly influence pellet growth [Figure 12]. As
previously shown in [1], ATDC5-Col2-gLuc luminescent response was responsive to a vitamin
K and copper supplemented chondrogenic media [Figure 13]. This indicates that the optimized
media condition is likely a stimulator of type II collagen promoter activity. However, the
ATDC5-PRG4-gLuc luminescence values decreased for both the theoretically and
experimentally optimized media conditions [Figure 13]. This indicates that while the vitamin K
and copper supplemented medias may stimulate type II collagen promoter activity, it has the
inverse effect for lubricin promoter activity. However, RT-qPCR data did not correlate closely
with these trends [Figures 14, 15]. This deviation from the luminescence activity can likely be
explained because of the relatively small quantities of RNA (<100 ng) and difficulty extracting
RNA from the cartilage tissue pellets. Additionally, the protein product of PRG4 is more stable
than the mRNA which it is produced from. The analysis of the mRNA by RT-qPCR at the end
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of the experiment will be affected by the temporal/cyclical regulation [54] of mRNA to a greater
extent than the final protein product. The histological slides produced in this experiment did not
stain significantly with Safranin-O, showing potentially low glycosaminoglycan production in
the cartilage tissue [Figure 16]. Otherwise, histological analysis demonstrated no noticeable
differences between media conditions.
HAC Lubricin Reporter Cell Development
Human articular cartilage cells isolated from discarded tissue following an osteoarthritic joint
replacement surgery were also infected by a lentiviral vector with PRG4 promoter driven
Gaussia luciferase plasmid. The infection was confirmed by puromycin selection and a
luciferase assay [Figure 17]. The HAC-PRG4-gLuc cell luminescent values were responsive to
increasing doses of TGF-β1 in both atmospheric and physioxic oxygen tensions [Figures 18, 19].
Although literature suggests that atmospheric oxygen tension would increase lubricin expression
[55] we did not find that, as raw luminescence values were similar between the two conditions.
This suggests that the luciferase activity in the human articular cartilage reporter cell is
correlated to TGF- β1 stimulated lubricin upregulation as seen in the ATDC5-PRG4-gLuc
reporter cells.
Future Studies
The HAC-PRG4-gluc reporter cells developed in this experiment will be used to further evaluate
the ATDC5 Col2A1 “optimized” media solutions detailed in [1]. Cell aggregates will be
utilized in addition 21-day experiments to assess the temporal effects of the multiple media
compositions in lubricin promoter activity. Additionally, the reporter cells can be utilized for
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analysis of natural products, drugs, and other potential chondrogenic stimulators and their effect
on lubricin promoter activity.
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CONCLUSION

The ATDC5 and human articular chondrocyte lubricin reporter cells developed in this
experiment provide a useful tool for the rapid, non-destructive, and temporal analysis of factors
which may influence lubricin stimulation in tissue engineered cartilage. The 2.2 µg/L of
Vitamin K and 670 ng/mL of Copper supplemented chondrogenic media produced increased
luminescence in the type II collagen ATDC5 reporter cell, while having decreased luminescence
in the lubricin reporter cell. Similarly, the theoretically optimized vitamin supplemented media
[Table 2] showed decrease luminescence in the ATDC5 lubricin reporter cell, without the
increase in the ATDC5 type II collagen reporter cell. These results highlight the difficulty in
developing cartilage with high levels of type II collagen and lubricin.
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APPENDIX A
Breakdown of ATDC5 Optimized Media Experiment Luciferase Data by Day
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Figure 20 – ATDC5 Optimized Media Experiment Luciferase Data: Days 2-9. These figures show the raw
luminescence readings for days 2-9 of the ATDC5 Optimized media experiment. For the ATDC5 pellets a statically
significant decrease in the theoretical media condition was seen starting at day 7. However, the values shown are
still consistent with a lack of luciferase activity and can be explained by the varying composition of the three
medias. Starting at day 9, a statistically significant increase in the optimized media condition for the ATDC5-Col2gLuc pellets was seen. Starting at day 7, a statistically significant decrease in the ATDC5-PRG4-gLuc pellets was
seen for the optimized media experiment. A one-way ANOVA test was performed for each pellet type between
each condition each day. Asterisks are shown for all P values below 0.05, additional asterisks indicate lower P
values.
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Figure 21 – ATC5 Optimized Media Experiment Luciferase Data: Days 14-21. These figures show the raw
luminescence readings for days 14-21 of the ATDC5 Optimized media experiment. Here the relatively lower
theoretical media values for the ATDC5 pellets remain consistent. Days 16 and 21 show a statistically significant
increase in the optimized media condition compared to both the control and theoretically optimized media
conditions for the ATDC5-Col2-gLuc pellets. Days 14-21 show a statistically significant decrease for both the
optimized and theoretically optimized media conditions for the ATDC5-PRG4-gLuc pellets. Asterisks are shown
for all P values below 0.05, additional asterisks indicate lower P values.

40

APPENDIX B
Breakdown of ATDC5 Optimized Media Experiment Pellet Area Data by Day
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Figure 22 – ATDC5 Optimized Media Experiment Pellet Area by Day: Days 2-7. A one-way ANOVA test was
performed for each pellet type between each condition each day. Asterisks are shown for all P values below 0.05,
additional asterisks indicate lower P values.
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Figure 23 – ATDC5 Optimized Media Experiment Pellet Area by Day: Days 9-14. A one-way ANOVA test
was performed for each pellet type between each condition each day. Asterisks are shown for all P values below
0.05, additional asterisks indicate lower P values.
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Figure 24 – ATDC5 Optimized Media Experiment Pellet Area by Day: Days 16-21. A one-way ANOVA test
was performed for each pellet type between each condition each day. Asterisks are shown for all P values below
0.05, additional asterisks indicate lower P values.
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